Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Firm with deep KC ties wins Small Business of the Year thanks to tenacity, hyperlocal focus
Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. A decades-long commitment to Kansas City clients — and the belief that rising tides lift all ships — helped propel Walz Tetrick Advertising to the award stage…
How this genre-hopping KC musician is fighting back against digitized entertainment
A former college football star, Keelon Vann often found himself “running on fumes” as he chased his passion on the field — and on key. “I’d be up playing guitar until 3 a.m., which is not a joke, and somehow make it to 5:30 a.m. workouts the next day,” said Vann, a quarterback at Piper High…
New collaboration will help OP startup 3D bioprint, scale its next-gen biotech solution
A Kansas biotech startup’s new manufacturing partner will boost efforts to automate and mass produce Ronawk’s headline-grabbing Bio-Block technology — a platform that has already accelerated medical advancements in tissue therapy. “Collaboration is critical for turning research advances into commercial therapies rapidly. The complexity and diversity of modalities is so big that nobody can do…
Museums shouldn’t feel like artifacts, KC firm says; Here’s how Multistudio uses analog experiences to build buzz
Multistudio doesn’t exclusively design museums, but the Westport-based architecture firm — along with Kansas City itself — certainly is having a museum moment, shared Robert Riccardi. The firm’s local portfolio includes a growing number of new-era museums, including The Rabbit Hole, the Laugh-O-gram animation studio, and the Satchel Paige House. They’re not your traditional museums…